Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125881231 | 12588123 | 1 | I | 20100723 | 20100928 | 20160725 | 20160725 | PER | US-CELGENEUS-163-21880-10092658 | CELGENE | 50.02 | YR | F | Y | 59.93000 | KG | 20160725 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125881231 | 12588123 | 1 | PS | REVLIMID | LENALIDOMIDE | 1 | Oral | U | UNKNOWN | 21880 | 25 | MG | CAPSULES | ||||||
| 125881231 | 12588123 | 2 | SS | REVLIMID | LENALIDOMIDE | 1 | Oral | U | UNKNOWN | 21880 | 10 | MG | CAPSULES | ||||||
| 125881231 | 12588123 | 3 | SS | REVLIMID | LENALIDOMIDE | 1 | Oral | 153 MILLIGRAM | U | UNKNOWN | 21880 | 10 | MG | CAPSULES | |||||
| 125881231 | 12588123 | 4 | SS | REVLIMID | LENALIDOMIDE | 1 | Oral | U | UNKNOWN | 21880 | 10 | MG | CAPSULES | ||||||
| 125881231 | 12588123 | 5 | SS | REVLIMID | LENALIDOMIDE | 1 | Oral | U | UNKNOWN | 21880 | 15 | MG | CAPSULES | ||||||
| 125881231 | 12588123 | 6 | SS | REVLIMID | LENALIDOMIDE | 1 | Oral | U | UNKNOWN | 21880 | 25 | MG | CAPSULES | ||||||
| 125881231 | 12588123 | 7 | SS | VELCADE | BORTEZOMIB | 1 | Intravenous drip | 1.3 MILLIGRAM/SQ. METER | U | U | UNKNOWN | 66188 | 2.1 | MG | INJECTION FOR INFUSION | ||||
| 125881231 | 12588123 | 8 | SS | DEXAMETHASONE. | DEXAMETHASONE | 1 | Oral | U | U | UNKNOWN | 0 | 20 | MG | UNKNOWN | /wk | ||||
| 125881231 | 12588123 | 9 | SS | ALKERAN | MELPHALAN | 1 | Intravenous drip | U | U | 0 | 153 | MG | INJECTION | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125881231 | 12588123 | 1 | Plasma cell myeloma |
| 125881231 | 12588123 | 7 | Plasma cell myeloma |
| 125881231 | 12588123 | 8 | Plasma cell myeloma |
| 125881231 | 12588123 | 9 | Plasma cell myeloma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125881231 | 12588123 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125881231 | 12588123 | Clostridial sepsis | |
| 125881231 | 12588123 | Febrile neutropenia | |
| 125881231 | 12588123 | Sepsis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125881231 | 12588123 | 1 | 20100518 | 20100528 | 0 | |
| 125881231 | 12588123 | 2 | 20100610 | 20100805 | 0 | |
| 125881231 | 12588123 | 3 | 20110517 | 20120705 | 0 | |
| 125881231 | 12588123 | 4 | 20120712 | 20130114 | 0 | |
| 125881231 | 12588123 | 5 | 20130115 | 20131220 | 0 | |
| 125881231 | 12588123 | 6 | 20160210 | 0 | ||
| 125881231 | 12588123 | 7 | 20100518 | 20100723 | 0 | |
| 125881231 | 12588123 | 8 | 20100518 | 20100805 | 0 | |
| 125881231 | 12588123 | 9 | 20100914 | 20100915 | 0 |